PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

This content item was originally published on www.outsourcing-pharma.com, a William Reed online publication.

By Melissa Fassbender contact

- Last updated on GMT

PPD Laboratories SVP says its been a substantial undertaking – for every company in the CRO industry – to meet the demand for biopharmaceuticals as the industry's pipeline continues to expand.

“I think it’s no secret within the industry that one of the fastest growing areas of demand for pharmaceutical companies has been their development needs for biopharmaceuticals,” ​said Jon F. Denissen, PhD, senior vice president, PPD Laboratories, at the company’s recently expanded facility in Middleton, WI.

To meet this demand, the contract research organization (CRO) has been expanding capacity globally. Most recently, PPD opened a 32,000 square-foot analytical laboratory, making room for more than 100 new employees.

“It’s been a substantial undertaking I think for every company in the CRO industry to keep up with demand for biopharmaceuticals,”​ Denissen told us after touring the new laboratory.

For a look inside the lab, and to hear more from Denissen on how the company is working to keep up with demand, catch our quick video above.

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us

Products

View more

Webinars